ERASMUS-BIODESIGN - Life long learning programme ERASMUS Multilateral action: BIODESIGN - Biodesign for health applications
From 01-10-2011 to 30-09-2013
Description
The recent EU publication of the Innovation Union Scoreboard brings the need for improved innovation initiatives in higher education institutions (HEIs) across Europe into sharp focus. The aim of this proposal is to address this ‘innovation emergency’ by developing a framework for undergraduate innovation in biomedical engineering which is suitable for implementation in HEIs across Europe. We propose the design and delivery of a novel educational module which offers practical, interdisciplinary and effective learning opportunities to undergraduate engineering and medical third level students across Europe. Specifically, BIODESIGN describes a module which is tailored towards integration of systematic innovation teaching tools with biomedical devices design learning in a multidisciplinary learning environment. While alternative educational modules in this space have emphasised the development of commercially viable devices as a core deliverable, the key objectives in BIODESIGN are learner-centered, focused on learning outcomes. The proposed module has a pedagogical focus which incorporates the following innovating elements: (1) creation of an integrative interdisciplinary learning environment; (2) introduction of a structured innovation process; (3) clinical immersion; (4) development of commercialisation and business plan development skills. The involvement of SME partners during both the development and delivery of module content ensures the transfer of industry-centered and employability skills. Bringing together a consortium of partners from medical education and engineering schools across several European countries, as well as enterprise partners, BIODESIGN combines the expertise of partners in these disciplines to formulate a targeted educational programme which addresses specifically the unsolved problem of educating for creativity and innovation (as applied to biomedical design) in third level education.
Team
- N. N., Co-promoter (External)
- Sabine Van Huffel, Co-promoter
- S. Jaecques KUL, Co-promoter (External)
- N. N., Co-promoter (External)
- Jozef Vander Sloten, Co-promoter (External)
- N. N., Co-promoter (External)
- N. N., Promoter (External)
- G Shorten, Promoter (External)
Financing
Funding: EU ERASMUS - Lifelong Learning Programee Erasmus & ERASMUS +
Program/Grant Type: LLP Erasmus Multi - Lifelong Learning Programme - Erasmus Multilateral Projects
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.